Loading AlgoFusionAI...

About Symbiotec Pharmalab Ltd.

Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients, nutritional ingredients, and specialty products. The company caters to domestic and international markets across regulated and emerging regions.

Competitive Strengths

Global leadership in corticosteroid and steroidal-hormone APIs

Long-standing relationships with domestic and global customer base

Fully-invested, multi-scale, vertically integrated manufacturing platform with sustainable practices and clean regulatory track record.

Continuous investment in R&D, with leading technological capabilities among Indian peers.

Ability to leverage science and existing competencies to increase total addressable market and deepen intellectual property-driven offerings

IPO Reservation

Category	Shares Offered	Percentage

Symbiotec Pharmalab Ltd. IPO GMP Today ₹0 | N/A IPO Price, Dates, Review 2026 | AlgoFusionAI